QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice

Background: Thrombolysis with tissue plasminogen activator (tPA) remains the only approved drug therapy for acute ischemic stroke. However, delayed tPA treatment is associated with an increased risk of brain hemorrhage. In this study, we assessed whether QiShenYiQi (QSYQ), a compound Chinese medicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yang, Li, Quan, Pan, Chun-Shui, Yan, Li, Sun, Kai, Wang, Xiao-Yi, Yao, Shu-Qi, Fan, Jing-Yu, Han, Jing-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790519/
https://www.ncbi.nlm.nih.gov/pubmed/35095486
http://dx.doi.org/10.3389/fphar.2021.759027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790519/
https://www.ncbi.nlm.nih.gov/pubmed/35095486
http://dx.doi.org/10.3389/fphar.2021.759027

Ejemplares similares